These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3291857)

  • 1. Proteus mirabilis urease. Partial purification and inhibition by boric acid and boronic acids.
    Breitenbach JM; Hausinger RP
    Biochem J; 1988 Mar; 250(3):917-20. PubMed ID: 3291857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular details of urease inhibition by boric acid: insights into the catalytic mechanism.
    Benini S; Rypniewski WR; Wilson KS; Mangani S; Ciurli S
    J Am Chem Soc; 2004 Mar; 126(12):3714-5. PubMed ID: 15038715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition studies of soybean (Glycine max) urease with heavy metals, sodium salts of mineral acids, boric acid, and boronic acids.
    Kumar S; Kayastha AM
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):646-52. PubMed ID: 20014894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boric acid and boronic acids inhibition of pigeonpea urease.
    Reddy KR; Kayastha AM
    J Enzyme Inhib Med Chem; 2006 Aug; 21(4):467-70. PubMed ID: 17059182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allicin from garlic inhibits the biofilm formation and urease activity of Proteus mirabilis in vitro.
    Ranjbar-Omid M; Arzanlou M; Amani M; Shokri Al-Hashem SK; Amir Mozafari N; Peeri Doghaheh H
    FEMS Microbiol Lett; 2015 May; 362(9):. PubMed ID: 25837813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances.
    Torzewska A; Rozalski A
    Microbiol Res; 2014; 169(7-8):579-84. PubMed ID: 24239192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Helicobacter pylori urease and purification of its subunits.
    Evans DJ; Evans DG; Kirkpatrick SS; Graham DY
    Microb Pathog; 1991 Jan; 10(1):15-26. PubMed ID: 1857197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-cell Proteus mirabilis urease inhibition by aminophosphinates for the control of struvite formation.
    Grela E; Dziełak A; Szydłowska K; Mucha A; Kafarski P; Grabowiecka AM
    J Med Microbiol; 2016 Oct; 65(10):1123-1129. PubMed ID: 27550502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of urease from Helicobacter pylori.
    Dunn BE; Campbell GP; Perez-Perez GI; Blaser MJ
    J Biol Chem; 1990 Jun; 265(16):9464-9. PubMed ID: 2188975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives.
    Abdullah MA; Abuo-Rahma GE; Abdelhafez EM; Hassan HA; Abd El-Baky RM
    Bioorg Chem; 2017 Feb; 70():1-11. PubMed ID: 27908539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of acetohydroxamic acid on the induction of bacterial ureases.
    Rosenstein I; Hamilton-Miller JM; Brumfitt W
    Invest Urol; 1980 Sep; 18(2):112-4. PubMed ID: 6997229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of urease activity by dipeptidyl hydroxamic acids.
    Odake S; Nakahashi K; Morikawa T; Takebe S; Kobashi K
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2764-8. PubMed ID: 1464106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of organic mercurials and sulfhydryl compounds on the urease activity of Proteus: inhibition by urine and ascorbic acid.
    Kunin CM
    Antimicrob Agents Chemother; 1976 Sep; 10(3):503-6. PubMed ID: 10828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the urease method for gentamicin assays.
    Bourne PR; Phillips I; Smith SE
    J Clin Pathol; 1974 Feb; 27(2):168-9. PubMed ID: 4596416
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of infected urinary stones by urease inhibition.
    Griffith DP; Musher DM
    Invest Urol; 1973 Nov; 11(3):228-33. PubMed ID: 4584162
    [No Abstract]   [Full Text] [Related]  

  • 18. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.
    Armbruster CE; Smith SN; Johnson AO; DeOrnellas V; Eaton KA; Yep A; Mody L; Wu W; Mobley HLT
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections.
    Milo S; Heylen RA; Glancy J; Williams GT; Patenall BL; Hathaway HJ; Thet NT; Allinson SL; Laabei M; Jenkins ATA
    Sci Rep; 2021 Feb; 11(1):3726. PubMed ID: 33580163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term studies of urease-induced crystallization in human urine.
    Edin-Liljegren A; Grenabo L; Hedelin H; Pettersson S; Wang YH
    J Urol; 1994 Jul; 152(1):208-12. PubMed ID: 8201667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.